...
首页> 外文期刊>International Journal of Pharmacy and Pharmaceutical Sciences >DEVELOPMENT AND EVALUATION OF DENTAL FILMS CONTAINING AN ANTIBACTERIAL AGENT FOR THE TREATMENT OF PERIODONTITIS
【24h】

DEVELOPMENT AND EVALUATION OF DENTAL FILMS CONTAINING AN ANTIBACTERIAL AGENT FOR THE TREATMENT OF PERIODONTITIS

机译:含抗菌剂的牙周膜的研制与评价

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Objective: The present study aims at the development and evaluation of controlled release dental films containing metronidazole in a carrier which consists of a common non-biodegradable polymer and various co-polymers in different concentrations for targeted delivery of drug and thus prolonging the action. Methods: Solvent casting method is adopted. Nine formulations were prepared with ethyl cellulose as the main polymer and co-polymers like PVPK30, HPMC K4M, Eudragit RS 100 in 3 concentrations (10, 20, 30%w/w of ethyl cellulose). Ethyl cellulose and co-polymers were dissolved in the solvent system, containing ethanol, chloroform and dichloromethane. Drug was dissolved in this mixture and mixed homogeneously and films were casted. These films were evaluated for thickness & content uniformity, swelling index, percentage moisture loss, in vitro drug release studies. Results: The best film was selected as the one which is prepared with ethyl cellulose and eudragitRS100 (20%w/w of ethyl cellulose) ie F8 since it can release the drug above MIC in each day of treatment and having sufficient drug content and other required characteristics. This formulation undergoes zero order release kinetics and non-Fickian diffusion mechanism. Conclusion: Ethyl cellulose - eudragit RS100 (20%w/w of EC) combination is the best carrier among the others for the preparation of metronidazole dental film for prolonging the drug action up to 10 days. Keywords: Metronidazole, Dental film, Periodontitis, Eudragit RS100, Local delivery.
机译:目的:本研究旨在开发和评估在载体中含有甲硝唑的控释牙科薄膜,该载体由普通的不可生物降解的聚合物和不同浓度的各种共聚物组成,用于靶向递送药物,从而延长了药效。方法:采用溶剂浇铸法。制备了以乙基纤维素为主要聚合物和共聚物(如PVPK30,HPMC K4M,Eudragit RS 100)的3种浓度(10、20、30%w / w的乙基纤维素)的九种配方。将乙基纤维素和共聚物溶解在溶剂系统中,其中包含乙醇,氯仿和二氯甲烷。将药物溶解在该混合物中并均匀混合,并流延薄膜。对这些膜的厚度和含量均匀性,溶胀指数,水分损失百分比,体外药物释放研究进行了评估。结果:选择最佳的薄膜是用乙基纤维素和eudragitRS100(20%w / w的乙基纤维素)即F8制备的薄膜,因为它可以在每天的治疗中释放高于MIC的药物,并具有足够的药物含量和其他所需的特性。该制剂经历零级释放动力学和非菲克扩散机制。结论:乙基纤维素-eudragit RS100(EC的20%w / w)组合是制备甲硝唑牙膜以延长药物作用长达10天的最佳载体。关键字:甲硝唑,牙膜,牙周炎,Eudragit RS100,本地分娩。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号